152 related articles for article (PubMed ID: 15494447)
1. Dystrophin- and MLP-deficient mouse hearts: marked differences in morphology and function, but similar accumulation of cytoskeletal proteins.
Wilding JR; Schneider JE; Sang AE; Davies KE; Neubauer S; Clarke K
FASEB J; 2005 Jan; 19(1):79-81. PubMed ID: 15494447
[TBL] [Abstract][Full Text] [Related]
2. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
3. MLP accumulation and remodelling in the infarcted rat heart.
Wilding JR; Lygate CA; Davies KE; Neubauer S; Clarke K
Eur J Heart Fail; 2006 Jun; 8(4):343-6. PubMed ID: 16330255
[TBL] [Abstract][Full Text] [Related]
4. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts.
Barnabei MS; Metzger JM
PLoS One; 2012; 7(3):e32880. PubMed ID: 22427904
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium.
Wehling-Henricks M; Jordan MC; Roos KP; Deng B; Tidball JG
Hum Mol Genet; 2005 Jul; 14(14):1921-33. PubMed ID: 15917272
[TBL] [Abstract][Full Text] [Related]
7. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
Lopez JR; Kolster J; Zhang R; Adams J
J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy.
Khairallah M; Khairallah R; Young ME; Dyck JR; Petrof BJ; Des Rosiers C
J Mol Cell Cardiol; 2007 Aug; 43(2):119-29. PubMed ID: 17583724
[TBL] [Abstract][Full Text] [Related]
9. Utrophin localization in normal and dystrophin-deficient heart.
Pons F; Robert A; Fabbrizio E; Hugon G; Califano JC; Fehrentz JA; Martinez J; Mornet D
Circulation; 1994 Jul; 90(1):369-74. PubMed ID: 8026021
[TBL] [Abstract][Full Text] [Related]
10. Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart.
Spurney CF; Knoblach S; Pistilli EE; Nagaraju K; Martin GR; Hoffman EP
Neuromuscul Disord; 2008 May; 18(5):371-81. PubMed ID: 18440230
[TBL] [Abstract][Full Text] [Related]
11. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
12. Role of diastolic properties in the transition to failure in a mouse model of the cardiac dilatation.
Costandi PN; Frank LR; McCulloch AD; Omens JH
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2971-9. PubMed ID: 16861693
[TBL] [Abstract][Full Text] [Related]
13. Hearts of surviving MLP-KO mice show transient changes of intracellular calcium handling.
Kemecsei P; Miklós Z; Bíró T; Marincsák R; Tóth BI; Komlódi-Pásztor E; Barnucz E; Mirk E; Van der Vusse GJ; Ligeti L; Ivanics T
Mol Cell Biochem; 2010 Sep; 342(1-2):251-60. PubMed ID: 20490897
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophy.
Heineke J; Kempf T; Kraft T; Hilfiker A; Morawietz H; Scheubel RJ; Caroni P; Lohmann SM; Drexler H; Wollert KC
Circulation; 2003 Mar; 107(10):1424-32. PubMed ID: 12642365
[TBL] [Abstract][Full Text] [Related]
15. Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.
Nakamura A; Harrod GV; Davies KE
Neuromuscul Disord; 2001 Apr; 11(3):251-9. PubMed ID: 11297940
[TBL] [Abstract][Full Text] [Related]
16. Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging.
Li W; Liu W; Zhong J; Yu X
J Cardiovasc Magn Reson; 2009 Oct; 11(1):40. PubMed ID: 19849858
[TBL] [Abstract][Full Text] [Related]
17. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters.
Ramachandran J; Schneider JS; Crassous PA; Zheng R; Gonzalez JP; Xie LH; Beuve A; Fraidenraich D; Peluffo RD
Biochem J; 2013 Jan; 449(1):133-42. PubMed ID: 23009292
[TBL] [Abstract][Full Text] [Related]
19. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
[TBL] [Abstract][Full Text] [Related]
20. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice.
Williams IA; Allen DG
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1969-77. PubMed ID: 17573457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
